Cita APA

Heynckes, S., Daka, K., Franco, P., Gaebelein, A., Frenking, J. H., Doria-Medina, R., . . . Heiland, D. H. (2019). Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme. BMC Cancer.

Chicago Style Citation

Heynckes, Sabrina, et al. "Crosslink between Temozolomide and PD-L1 Immune-checkpoint Inhibition in Glioblastoma Multiforme." BMC Cancer 2019.

Cita MLA

Heynckes, Sabrina, et al. "Crosslink between Temozolomide and PD-L1 Immune-checkpoint Inhibition in Glioblastoma Multiforme." BMC Cancer 2019.